Doctors’ beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention
- 26 January 2002
- journal article
- research article
- Published by Wiley in Internal Medicine Journal
- Vol. 32 (1-2) , 15-23
- https://doi.org/10.1046/j.1445-5994.2002.00156.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhagesQJM: An International Journal of Medicine, 2000
- Clopidogrel and thrombotic thrombocytopenic purpuraThe Lancet, 2000
- Warfarin for Stroke Prevention Still Underused in Atrial FibrillationStroke, 2000
- Preventing ischemic strokePostgraduate Medicine, 2000
- Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patientsPublished by Wiley ,2000
- Review of antithrombotic drug usage in atrial fibrillationJournal of Clinical Pharmacy & Therapeutics, 1998
- Thromboembolism Prophylaxis in Chronic Atrial FibrillationStroke, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Atrial fibrillation, anticoagulation, and strokeThe American Journal of Cardiology, 1996
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993